(Reuters) - Merck & Co Inc said on Thursday a key late-stage trial testing its blockbuster drug, Keytruda, failed to meet its main goal of... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/gImoB__QTG4/mercks-keytruda-fails-pivotal-gastric-cancer-trial-idINKBN1E835K
LOS ANGELES (Reuters) - Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/5lKrcqaKFGo/merck-raises-stakes-in-lung-cancer-as-rivals-close-in-idINKBN1E50F1
Amneal Pharmaceuticals is set to pip Sun Pharma as the fifth largest generics maker in the US, reports Sohini Das. Illustration: Dominic... ...http://www.rediff.com/money/report/how-desi-brothers-built-a-18-bn-drug-co/20171130.htm
By Sruthi Shankar (Reuters) - A rebound in industrials pushed the Dow Jones Industrial Average higher on Monday, while the technology-led gains in... ...http://www.sify.com/finance/industrials-techs-lift-wall-street-health-stocks-limit-gains-news-equity-rluuuMhcacdgj.html
Reuters Staff 2 Min Read (Reuters) - Merck & Co Ltd’s drug to prevent serious infection in patients who undergo a type of stem cell... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/S_NKMgM1GoQ/fda-oks-merck-drug-that-prevents-infection-post-stem-cell-transplant-idINKBN1D91V3
Welcome Greetings! To our esteemed...